Back
Top 0.1%
23.7%
Top 1%
11.7%
Top 0.2%
9.6%
Top 64%
8.3%
Top 23%
6.8%
Top 0.6%
5.4%
Top 4%
4.1%
Top 6%
2.1%
Top 5%
2.1%
Top 19%
2.1%
Top 41%
1.7%
Top 1%
1.4%
Top 13%
1.4%
Top 22%
1.4%
Top 10%
1.4%
Top 8%
1.3%
Top 4%
1.2%
Top 0.2%
1.0%
Top 0.8%
0.8%
Top 8%
0.8%
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: a cost-utility analysis
2026-01-11
health economics
Title + abstract only
View on medRxiv
Show abstract
BackgroundRespiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections and hospitalizations among infants in Canada. New long-acting monoclonal antibodies (mAbs) and vaccines administered during pregnancy have expanded prevention options, yet the most cost-effective immunization program remains uncertain. MethodsWe updated a Canadian cost-utility model to evaluate seven seasonal RSV prevention strategies over one year (with a lifetime horizon for mortality impacts)...
Predicted journal destinations
1
Vaccine
140 training papers
2
Clinical Infectious Diseases
219 training papers
3
BMC Medicine
155 training papers
4
PLOS ONE
1737 training papers
5
BMJ Open
553 training papers
6
PLOS Medicine
95 training papers
7
JAMA Network Open
125 training papers
8
The Journal of Infectious Diseases
137 training papers
9
Open Forum Infectious Diseases
124 training papers
10
PLOS Global Public Health
287 training papers
11
Nature Communications
483 training papers
12
eClinicalMedicine
55 training papers
13
BMJ Global Health
95 training papers
14
BMC Public Health
148 training papers
15
Proceedings of the National Academy of Sciences
100 training papers
16
Vaccines
131 training papers
17
BMC Health Services Research
43 training papers
18
Canadian Medical Association Journal
15 training papers
19
npj Vaccines
18 training papers
20
The Lancet Infectious Diseases
57 training papers